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 List of Abbreviations: 
Pt.#    Patient number 
GA Deliv  Gestational Age at Delivery 
Dur.Adm Duration of hospital admission 
Birthweight  Newborn Weight at Birth in grams 
GP   Gravity/parity 
Di. Di.Twins Dichorionic-Diamniotic Twins 
GW   Gestational Week Patient was first seen 
GA Adm.  Gestational Age on Admission 
Len. Adm. Length of hospital Admission 
Prior OP  If Patient had a prior gynaecological operation 
 Fibr@Deliv  Fibroid size at Delivery 
Fibr remov  Whether Fibroid was removed at Delivery - or in the cases with 
the gestational age written in –the fibroid was removed during the 
pregnancy at the corresponding gestational week 
Op gestational week at which patient underwent myomectomy 
Mode Deliv. Mode of Delivery 
prim. Cesa. Primary Caesarean  
Sek. Cesa secondary Caesarean 
spont. Spontaneous vaginal delivery 
Vacuum spontaneous vaginal delivery assisted via vacuum  
conserv. Conservative medical therapy 
LSK diagn.  Diagnostic Laparoscopy 
LSKM  Laparoscopic Myomectomy 
LapM  Myomectomy via Laparotomy 
CRP  elevated C-Reactive protein 
HE   Hysterectomy 
Complica  Complication following Delivery 
Prem. Cxs. Premature Contractions 
Vag. Bleeding Vaginal Bleeding 
Hydron. Hydronephrosis 
Abd. Pain Abdominal pain 
Reop   Reoperation 
Postp.fever postpartum fever
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1. Introduction 
 
Uterine fibroids are found in approximately 2-4% of pregnant women, making 
them the most common solid pelvic tumour encountered during pregnancy. 
[Burton et al., Katz et al. 1989] Sixty percent of these pregnancies usually 
remain asymptomatic whereas in approximately ten to forty percent of 
patients, complications may arise either during pregnancy or during 
postpartum [Burton et al. 1989, Exacoustos et al. 1993]. The most common 
complications arising from fibroids in pregnancy include an increased 
frequency of spontaneous abortion, placental abruption, premature rupture of 
membranes, premature labour, postpartum haemorrhage and postpartum 
sepsis [Rice et al. 1988, Exacoustos et al. 1993, Katz et al. 1989, Coronado et 
al. 2000].  
 
The clinical management of uterine fibroids during pregnancy is primarily 
medical, but in cases of failed medical treatment, surgical intervention via 
myomectomy should be considered. 
  
The goal of our study was to observe the possible complications that may 
arise from large uterine fibroids in pregnancy, the effectiveness of medical vs. 
surgical therapy, and the ability to determine the appropriate modality for the 
appropriate patient. 
  
In this study we present the pregnancy outcomes in our obstetrics department 
of 12 medically treated patients with large uterine fibroids. From these 12 
patients 3 were carefully selected and surgically treated, undergoing a 
myomectomy during their pregnancy. 
 
2. Materials and Methods  
 
Nineteen pregnant patients, all with large uterine fibroids (>8cm) presenting at 
Klinikum Grosshadern, a German university clinic and tertiary referral centre, 
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between 1996 and 2007, either for routine pregnancy ultrasound or admitted 
with pregnancy complications, were retrospectively followed throughout their 
pregnancy, delivery and postpartum. Data was collected via confidential 
patient charts as well as labour and delivery log, the ultrasound Viewpoint 
program from General Electric, and the confidential clinical data base of the 
university clinic Grosshadern. In cases of lost follow up, patients or their 
treating gynaecologists were contacted via telephone for details up to and 
including delivery. All patients received an initial ultrasound documenting the 
number, size and position of their fibroids as well as follow up ultrasounds 
documenting their potential growth, as well as growth of the fetus. All 
ultrasounds were performed by obstetricians/gynaecologists with special 
training in obstetrical sonography. 8(42%) Patients received a pelvic MRI in 
addition to Ultrasound. These were Patients with rather large fibroids with 
documented central necrosis and growth of the fibroid during pregnancy. 
 
The 19 Patients had a mean age of 35 years, ranging from 26 to 42 years of 
age, 12 (63%) were nulliparous vs. 7(37%) multiparous. The fibroids were 
evaluated for size, number, position, and location in relationship to the 
placenta and sonografic echotexture (important in the evaluation of 
degenerating fibroids). Ultrasonographic confirmation of the myoma was 
based on the criteria described by Muram and Colleagues [Muram et al. 1980]: 
1) spherical mass with a diameter equal to or greater than - in our study 
population 8cm 2) distortion of the myometrial contour by the mass, and 3) 
differentiation of the mass from the myometrium by different variations in 
echogenicity as seen by ultrasonography [Muram et al. 1980, Rosati et al. 
1992]. The classification of the fibroids was based on Benson`s described 
criteria (Benson et al., 2001) and subdivided into 1) submucosal: protrusion of 
a part of the fibroid into the uterine cavity, 2) intramural: fibroid growing within 
the uterine myometrium and 3) subserosal: fibroids extending externally to the 
serosa. 
 
Patients who underwent myomectomy during pregnancy were more likely to 
have symptoms resistant to medical therapy. The criteria for deciding which 
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patients underwent myomectomy during their pregnancy were: 1) persistent 
symptoms resistant to conservative medical therapy (listed below), 2) rapid 
growth of the fibroid during pregnancy (documented via ultrasound or MRI), 3) 
retroplacental location of fibroid, and 4) signs of fibroid myxoid degeneration or 
central necrosis.  Conservative medical therapy consisted of ice pack cooling, 
thrombosis prophylaxis with Heparin (due to strict bed rest), tocolytics 
(magnesium sulfate, 1µg/min Fenoterol (ß-sympathomimetic; Partusisten®, 
Boehringer Ingelheim Pharma, Ingelheim, Germany) analgesics (Buscopan, 
Boehringer, Paracetamol), in cases of increased CRP and presumed infection 
(Augmentan®, SmithKline Beecham Pharma, Munich, Germany), intravenous 
fluid and prostaglandin inhibitors (Ibuprofen), as well as  (Betamethason -
Celestan®, Essex Pharma, Munich; Germany ) for induction of lung maturation 
when deemed appropriate. All patients underwent fetal vitality monitoring via 
ultrasound, as well as cardiotokographic documentation of contractions. 
 
All myomectomies were performed in the second trimester (19th week and 21st 
week of pregnancy) following informed consent via laparotomy and with the 
use of a cell-saver to minimise blood loss. Postoperative fetal monitoring via 
ultrasound and tocolysis (magnesium sulfate and Partusisten, Boering) 
assured fetal well being. All patients were compared as to their complaints 
leading to hospital admission, length of admission prior to delivery, length of 
pregnancy as well as fetal outcome and occurrence of postpartum 
complications. 
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3. Description of Patients 
 
Patient 1 
 
40 year old G1P0-was admitted repeatedly in a different hospital between the 
7th and 14th week of pregnancy with vaginal bleeding. The patient was finally 
transferred to Klinikum Großhadern in the 14th week, following an on/off 
admission time of 4 weeks at the initial hospital, with the question of 
myomectomy vs. continuous conservative therapy. At the time of admission, 
the patient had light intermittent vaginal bleeding, but no abdominal pain or 
other symptoms. A single cervical transmural fibroid measured 12cm x 10cm x 
9cm on admission (ultrasound and MRI) which within 3 weeks had increased 
to 17cm x 18cm x 12cm. A second smaller cervical fibroid measured 3,5cm x 
5x4cm. On MRI the fibroid showed an inhomogeneous signal which indicated 
a subacute earlier blood clot. The edge of the placenta contacted the two 
fibroids, and the two cervical fibroids distorted the natural birth canal. 
Interestingly enough there always seemed to be a two week discrepancy 
between the size of the fetus and the gestational age based on ultrasound.  
 
The patient received conservative management during her admission over the 
span of roughly a week and was discharged after remaining asymptomatic and 
without any further vaginal bleeding, to outpatient control every two weeks. 
The patient delivered a 2820 gram healthy male fetus via primary caesarean 
(due to the distortion of the birth canal), in the 39th week.  APGAR (neonatal 
assessment score named after Virginia Apgar) were 9 at 5 minutes and 10 
following 10 minutes. The main cervical fibroid at the time of delivery was over 
20cm and was left in place. The patient was discharged a week after delivery 
without any postpartum complications. 
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Patient 2 
 
37 year old G1P0 who was admitted in the 14th week of pregnancy because of 
abdominal pain. A 12cm x 12cm transmural posterior wall fibroid without signs 
of necrosis was documented via ultrasound. In addition a 6,5cm subserosal 
right sided and 3,5cm subserosal fundal fibroid were documented. The patient 
was conservatively managed and was discharged after 2 weeks. The fibroids 
showed minimal growth throughout the pregnancy. No MRI was performed in 
this patient. The patient delivered a healthy 3100g female infant (APGAR 9 
and 10) at a different hospital in the 41st week via secondary caesarean, 
following premature rupture of membranes and arrest in the second phase of 
labour. At the time of caesarean, the patient had an 8x8cm intramural right 
sided fibroid. The placenta was anterior. No complications postpartum were 
noted. The patient was discharged with the recommendation to have a 
myomectomy prior to future pregnancy. 
 
 
Patient 3 
 
33 year old G1P0 who was admitted in the 21st week of pregnancy with 
abdominal pain, fever and increased infection parameters in blood. The patient 
had a 15cm x 12cm intramural fundal fibroid (Image 1) and was treated 
conservatively with antibiotics, cooling, pain medication and anticoagulation 
over a period of 13 weeks. In the 26th week the patient had nausea, and right 
upper quadrant abdominal pain despite non rising infection as well as liver 
enzyme parameters. An examination of the gallbladder was within normal 
limits. The patient continued to be managed conservatively, and remained 
stable up until the 32nd week where she again started complaining of right 
upper quadrant abdominal pain, most likely attributed to the growing fribroid 
and possibly its inner necrosis.  In the 34th week (33+2) following RDS 
prophylaxis, and due to premature labour and an increase of the fibroid size to 
25cm, the patient was delivered via caesarean, without removal of the fibroid-
due to the increase risk of bleeding. (Image 2 and Image 3). The female 
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newborn weighed 1890 gram (10% in the 34th week-1973g) and was healthy 
(Apgars 8/9).  
 
Four days following the caesarean the patient underwent a CT scan of the 
abdomen due to worsening of her condition. The CT showed free fluid in the 
abdomen and bilateral plural effusions, but no signs of a hematoma or 
abscess. An increase in the size difference of the patient´s legs as well as pain 
led to a doppler ultrasound to rule out a deep vein thrombosis. This as well as 
a spiral CT to rule out a pulmonary embolism were both negative.  Due to an 
acute abdomen and fear of a uterine torsion due to the large remaining fibroid 
the patient was re-operated with the diagnosis of chronic appendicitis and a 
fibroid removal was performed during the same operation (Image 4). 
 
Overnight the patient lost a considerable amount of blood vaginally which 
was unable to be stopped conservatively and was taken to the operating 
room again. An abdominal hysterectomy (Image 5) was necessary due to 
diffuse bleeding in the placenta insertion areas, which was unable to be 
stopped following one hour of conservative methods. The patient received 8 
packs of Red Blood Cells and 8 Units of Fresh Frozen Plasma, and was 
stabilised at a Haemoglobin of 8,9 g/dl at the time of discharge (almost 4 
weeks after her initial caesarean). 
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Image 1: Ultrasound depiction of large fibroid 
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Image 2:  Twisting of the pregnant uterus due to large fibroid  
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Image 3:  Re-laparotomy and removal of fibroid 
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Image 4:  Fibroid removed 4 days following Cesarean due to acute abdomen 
 
 
Image 5:  Necrotic fibroid 
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Patient 4 
 
29 year old G1P0 having undergone a myomectomy one year prior where a 
posterior wall fibroid measuring 5cm was removed via laparotomy. The patient 
was admitted with abdominal pain in the 15th pregnancy week and was found 
to have multiple fibroids, the largest of which was a cervical fibroid measuring 
15cm x 13cm. The patient was admitted for a total of three weeks and 
conservatively managed, and following discharge continued to be followed as 
an outpatient. The fibroid showed minimal growth, throughout the remainder of 
the pregnancy, however an MRI in the 26th week of pregnancy showed the 
uterine wall at the fundus as being less than 1cm thick, (Image 6) with a left 
sided lateral placenta. In the 28th week the patient was found to have 
polyhydramnion although TORCH and OGTT (oral glucose tolerance test) 
results were all normal. The patient was admitted again in the 31st week due to 
premature contractions and remained under close observation until delivery in 
the 32+6 week of pregnancy via primary caesarean, due to an extreme fibroid 
uterus. At the time of caesarean a hysterectomy was also performed, due to 
the inability to re-approximate the uterus as a result of its hypertrophy. The 
2120 gram male infant with Apgars of 8/8, required CPAP (continuous positive 
airway pressure) over a few days, but was otherwise healthy. The uterus 
according to the pathology report weighed 3560 grams and was 30cm x 20cm 
x 20cm large. 
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Image 6:  MRI 26+0 weeks of pregnancy - myometrium at fundus less than 
1cm in Patient 4 
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Image 7:  Uterus showing necrotic edges unable to be re-approximated in   
Patient 4 
 
Patient 5 
 
38 year old G2P1 with a prior caesarean delivery 2 years prior and a 
laparoscopic fibroid enucleation of a 4cm posterior wall fibroid two years 
before that, with documented opening of the uterine wall. The patient was 
seen in the 22nd week of pregnancy due to vaginal bleeding and abdominal 
pain. An MRI in the 22nd week showed a left lateral intramural 13,8cm x 7cm 
fibroid, as well as multiple intramural fibroids and one 4,2cm submucosal 
fibroid on which the fetus was lying. The patient was observed as an 
outpatient and was delivered via primary caesarean in the 39th week of a 
3580g healthy, male infant. At the time of caesarean no mention of a 
submucosal fibroid was made. 
 
Two weeks following the delivery the patient had increased infection 
parameters (CRP-C-Reactive Protein max. 20,6mg/dl-normal under 0,5mg/dl) 
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and an abdominal CT showed possible fibroid necrosis. The patient was 
treated conservatively with analgesics and antibiotics and was discharged. 
 
Patient 6 
 
29 year old G2P0 with dichorionic–diamniotic twins following ICSI, and a 
known fibroid uterus.  Prior to the pregnancy, a diagnostic laparoscopy for 
infertility had been performed. The patient was admitted in the 9th week due to 
vaginal bleeding-but was discharged within 4 days, and war readmitted in the 
11th week due to abdominal pain. In the first admission a 9cm subserosal 
Fundus fibroid was discovered, and two weeks later diffuse fibroids were seen 
from portio to fundus measuring 15cm x 10cm. The patient was observed as 
an outpatient and was readmitted in the 25+2 gestational week with premature 
contractions. The patient was treated with antibiotics (Augmentan®, 
SmithKline Beecham Pharma, Munich, Germany) and tocolysis (magnesium 
sulfate and Partusisten , Boering) as well as 2  injections of Betamethason 
(Celestan®, Essex Pharma, Munich, Germany ) for RDS (Respiratory Distress 
Syndrome) prophylaxis. However increasing infection parameters (CRP 
6,3mg/dl) and premature rupture of membranes, with green coloured amniotic 
fluid and cervical dilation to 2cm with prolapse of a foot in the cervical canal, 
led to a clinical diagnosis of amniotic infection syndrome, and the patient was 
delivered via secondary caesarean (longitudinal) in the 25+4 week of 
gestation. The 750 gram female and 770gram male infant (both with APGARS 
8/8) were intubated, but otherwise discharged after 8 weeks in the neonatal 
intensive care unit, healthy and without long term problems. 
 
Four fibroids were removed at the time of the caesarean section, one of which 
interfered with uterine incision closure. 
 
 
  
15 
 
Patient 7 
 
38 year old G3P2 with a laparoscopic myomectomy 6 years prior, followed by  
2 spontaneous term deliveries who presented for delivery registration, 
asymptomatic, during the current pregnancy in spite of a documented 12cm x 
10cm uterine fibroid located in the cervical region. The patient was delivered 
via primary caesarean in the 39th week of gestation delivering a 2730g infant 
with APGAR (9/10). The assessment of the uterus intra-operatively deemed a 
very difficult repair with an intraligamentary cervical fibroid and due to 
completed family planning, a hysterectomy was performed after obtaining  
patient consent (Image 12). 
 
 
Image 8:  Intraligamentary cervical fibroid and Uterus - Cesarean hysterectomy in 
Patient 7 
 
 
Patient 8 
 
33 year old G2P0 (one missed abortion in the 8th week) presented at 17 weeks 
of pregnancy with a subserosal 14cm x 11cm x 10,7 cm fundal uterine fibroid 
and a few posterior wall fibroids, who was admitted in the 19th week due to 
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abdominal pain and feeling of abdominal fullness. The fundal fibroid reached 
almost to the patient´s sternum, and was confirmed via MRI as being almost 
15cm and showing degenerative changes. The patient was aware of her 
fibroids but had not been recommended to have her fibroids removed prior to 
getting pregnant. The patient underwent at first conservative therapy but due 
to the rapid growth in size of the fibroid (the referring physician documented a 
6cm growth within 4 weeks) and the risk of a potential sarcoma, the patient 
underwent a myomectomy in the 19th week of pregnancy. A subserosal fundal 
myoma (14.5cm x 14.5cm x 13.0cm; 1570g) was removed, under general 
anesthesia. The uterine cavity was opened, exposing the dorsal plane of the 
fundal placenta but without rupture of the amniotic membranes. Other 
additional fibroids on the posterior wall were left intact to avoid a second 
trasmural defect. Perioperative normovolemic hemodilution and intraoperative 
blood salvage reduced blood loss during the operation and prevented the 
need of postoperative transfusion. The histopathological examination of the 
fibroid showed 6 mitosis per high power field, minimal cell atypia, focal 
regressive changes and necrosis, all of which classified the fibroid as a 
neoplasia of uncertain malignant potential. As a result of this diagnosis, the 
remaining fibroids were examined via ultrasound and MRI every 4 weeks, 
without further growth being observed for the remainder of the pregnancy.  
The patient underwent an MRI of the thorax which showed no pulmonary 
metastasis 
  
The patient had an uncomplicated further pregnancy and was delivered at 36 
weeks of gestation via caesarean, to avoid the onset of spontaneous labour 
due to increased uterine rupture risk following myomectomy. The baby was a 
2495gram healthy female infant with (APGAR 8/8/9). At the delivery it was 
noted for the first time that the newborn was missing the right hand up to the 
wrist. The family history was empty for limb defects. 
 
At the time of cesarean, biopsies were taken from the prior site of the fibroid. 
No signs of increased mitosis was found. 
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Image 9:  Focally increased cellularity, mitotic activity and minimal cellular atypia 
in the smooth muscle tumor. H+E object magnification 64x in Patient 8 
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Image 10:  Focal regressive changes with necrosis. H+E, object magnification 10x 
in Patient 8 
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Mitoses/10 
HPF 
Atypia Cellularity Diagnosis 
0 – 4 - Normocellular (Typical) leiomyoma 
0 – 4 - Hypercellular Cellular leiomyoma 
0 – 4 + Variable Atypical leiomyoma 
5 – 15 - Normocellular Mitotically active leiomyoma 
> 5 Minimal Hypercellular Leiomyomatous neoplasia of 
uncertain malignant potential 
> 5 + Hypercellular Leiomyosarcoma 
 
Table 1:  Histologic criteria for the diagnosis of uterine smooth muscle tumors 
(HPF = High power field; mod. from Zaloudek and Norris, 1994)  
 
 
Patient 9 
 
The patient was admitted in the 19th week of pregnancy due to abdominal 
pain. The patient was found to have a 14cm fibroid, which was removed due to 
persisting symptoms in the 19th week and weighed in at 1420gram. The 
patient was delivered in the 37th week via primary caesarean and had an 
uneventful postpartum. 
 
 
Patient 10  
  
42 year old G2P1 with prior caesarean due to preeclampsia in the 38th week, 
presented in the 18th week of pregnancy with right hydronephrosis and 
abdominal pain. The patient had a known fibroid uterus, which had been 
followed the prior 3 years and had been treated with ultrasound waves, with 
minimal reduction in size of the fibroids (fibroid 7,3cm x 5,4 cm one year prior 
to pregnancy). At her admission an ultrasound showed a normally developed 
fetus in the 18th week, with a large inhomogeneous fibroid 14cm x 12cm on the 
right side of the uterus, adjacent to the cervix and the placenta, with central 
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necrosis. A placenta previa was also seen, and the patient had some bleeding 
in the early pregnancy. 
 
The patient was observed and conservatively treated over the next 3 weeks 
until the decision to undergo a myomectomy during the pregnancy was met, 
because of the continued signs of necrosis seen sonographically as well as via 
MRI and the worsening hydronephrosis which was anticipated would cause 
future problems in the remaining months of pregnancy. A myomectomy of the 
12cm necrotic Cervix fibroid as well as of a 4cm pedunculated posterior wall 
fibroid was performed in the 21st week of pregnancy, using monopolar electric 
current and closing the bed with single vicryl stitches. The fetus and patient 
tolerated the operation well, and the patient was seen as an outpatient in the 
27th week, with reduced hydronephrosis and an appropriately growing fetus. In 
the 28th gestational week the patient was admitted to her neighbourhood 
hospital due to a partial placenta previa and placenta acreta. Further 
ultrasounds disputed a placenta previa but due to increased vascularisation in 
the lower uterine segment a primary caesarean was performed in the 36th 
week. The female infant weighed 2570g and had Apgars of 9/10. During the 
caesarean the placenta was removed uneventfully, however a hysterectomy 
was performed, due to uncontrollable bleeding in the lower uterine segment. 
The patient received a blood transfusion of 2 units Red Blood Cells. 
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Image 11:  Large Uterine Fibroid at intrapartal myomectomy in Patient 8 
 
 
Image 12:  Pregnant Uterus following intrapartal myomectomy in Patient 8 
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Patient 11 
 
33 year old G1P1 who was followed as an outpatient throughout the 
pregnancy. The patient was first seen in the 11th week with a 11,4cm x 8,7cm 
x 11,7cm fundal uterine fibroid. The patient was closely followed as an 
outpatient, with ultrasounds every 2-4 weeks, without any documentation of 
fibroid growth, and no signs of central necrosis. The patient remained 
asymptomatic throughout her pregnancy. The patient was last seen in the 
clinic in the 37th week with normal fetal measurements and was then delivered 
via vacuum in the 38th week of gestation due to a protraction of the second 
phase of labour and green amniotic fluid. The healthy 2610g male infant had 
APGAR 10/10. The fundal uterine fibroid measured 10cm x 10cm (smaller 
than initially) and was left in place. The patient was discharged without any 
postpartum complications. 
 
 
Patient 12 
 
30 year old G2P0 seen in the clinic once during her 33rd week of pregnancy 
with a 8,0cm x 8,0cm fibroid, which according to the patient had grown during 
the pregnancy. The patient was admitted due to abdominal pain and 
premature labour with a 1cm long cervix. In spite of tocolysis and RDS 
prophylaxis the patient delivered in the 33rd week of pregnancy spontaneously 
a 2110 gram healthy, female infant APGAR 9/9. The placenta showed no 
signs of chorioamnionitis. 
 
The patient was contacted a few years after delivery and mentioned that one 
year following delivery, the fibroid had gotten smaller (5cm), but because of 
abdominal discomfort it was eventually removed via laparoscopy. 
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Patient 13 
 
26 year old G1P0 with a known fibroid prior to pregnancy measuring 5cm. The 
patient was first seen in the clinic in the 16th week of gestation where the 
fibroid measured 8,5cm x 8,6cm x 9,5cm, and was found to be lying near the 
placenta bed according to the ultrasound examination with central fluid 
necrosis. The patient was asymptomatic. A MRT showed an 8,6cm x 8,2cm 
x7,5cm intramural fibroid with central necrosis  and fluid, but without any 
relation to the posterior placenta.  Follow up outpatient control showed an 
increase in the fibroid growth, measuring 9,7cm x 9,0cm x 7,7cm with central 
echoes in the 20th gestations week, with normal biometric measurements of 
the fetus. 
 
The patient remained asymptomatic and was followed as an outpatient. She 
delivered spontaneously in the 42nd week of pregnancy a 3500g infant with 
APGAR 10/10. The 10cm fibroid was left in place and caused no 
complications postpartum. 
 
The patient was contacted a few years following her delivery and she reported 
having had a second uncomplicated spontaneous delivery two years after the 
first. The fibroid is still present and not causing any symptoms. 
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Patient 14 
 
35 year old Pt. G1p1 was admitted in the 10th week of pregnancy with a large 
fibroid uterus, abdominal pain, and increased infection parameters.  The 
patient was treated conservatively with intravenous antibiotics, and pain 
medication. The diagnosis was one of presumed central necrosis of the 11cm 
x 8cm uterine fibroid.  In addition, a 7,3cm x 7,0cm fibroid was also seen. The 
patient was released asymptomatic a week later with normal blood levels and 
no further fibroid growth. The patient was followed on an outpatient basis with 
a normal documented fetal growth and normal doppler parameters. 
 
In the 39th week of pregnancy due to contractions and deceleration on CTG, it 
was decided to deliver via caesarean.  A 3330g, female fetus with APGARS 
10/10 was born. On further inspection of the uterus a 12cm x 8cm fibroid with 
a three cm. base, consistent with the growing myom in the pregnancy was 
found but left in place. 
 
 
Patient 15 
 
42 year old G2P1 (one spontaneous delivery 7 years prior at which point no 
fibroids were known), had a spontaneous pregnancy following years of 
infertility and numerous inseminations. Prior to the pregnancy, the patient was 
known to have a fibroid uterus with at least three fibroids the largest of which 
was 5cm. The patient was seen in the ultrasound ambulance in the 8th week at 
which time her fibroid measured 8,6cm x 6,5cm x 5,0cm. The patient 
continued to remain asymptomatic throughout an uneventful pregnancy, 
without complications through the fibroid.  
 
She delivered in the 41st week via secondary caesarean due to vaginal 
bleeding of which the cause was thought to be either uterine rupture (with a 
sonographically measured uterine thickness of less than 0,5cm) or placental 
abruption.  At the time of caesarean no uterine rupture was found, but sinus 
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bleeding due to a partial placenta separation (anterior placenta), as well as a 
8cm intramural fibroid in the right isthmical area. A 3260g normally developed 
female infant APGAR 10/10 was delivered. The fibroid was left intact and the 
patient had an uneventful postpartum.  
 
The patient was contacted a few years following delivery, and reported that the 
fibroid had decrease to 4cm following delivery. It managed however to grow 
slowly again over the 8 years following delivery to a maximum of 10cm at 
which time it was surgically removed. 
 
 
Patient 16 
 
37 year old G3P3 with two prior spontaneous deliveries and known uterine 
fibroids and gestational diabetes in the current pregnancy. The patient 
remained asymptomatic and was followed as an outpatient throughout the 
pregnancy. The multiple fibroids (5 all together) of which the largest measured 
8,9cm x 8,4cm x 7,2cm transmural right in the 28th week did not show any 
increase in growth throughout the pregnancy (followed every two weeks 
sonographicaly till 37th week).  A 1,8cm submucosal anterior wall fibroid was 
also documented. The placenta was posterior and without contact to fibroids. 
 
The patient delivered vaginally in the 38th week a 3420g healthy male infant, 
APGAR 9/9 and had an uncomplicated postpartum. 
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Patient 17 
 
39 year old G3P2 who was first seen asymptomatic in the 12th week of 
gestation, with a 9cm x 8cm x 8cm right wall fibroid. The same fibroid seemed 
unchanged in the 20th week fetal organ scan. The placenta was anterior. The 
pregnancy continued uneventfully and the patient remained asymptomatic 
from her fibroid.  
 
The patient underwent induction of labour due to uncontrollable hypertension, 
(the patient was hypertensive also prior to the pregnancy and had Pregnancy 
induced hypertension with the first two pregnancies) and was delivered 
spontaneously in the 35th week of a healthy 2539g male infant. APGARS 9/10. 
 
The patient was contacted a few years following delivery, and she reported still 
having a currently 9cm asymptomatic fibroid.  
 
 
Patient 18 
 
33 year old G1P0 first seen in the 10th gestational week with two large 
intramural fibroids measuring 6,8cm x 6,2cm x 6,0cm and 8,8cm x 8,0cm x 
8,5cm respectively. The patient remained asymptomatic and a follow up 
measurement of her fibroid in the 19th week showed growth to 11cm x 9cm 
inhomogeneous with central necrosis and adjacent to the placental edge 
(placenta posterior). The fibroid continued to grow, measuring 14cm x 7,3cm x 
7,9cm in the 26th week of gestation.   
 
The patient was followed as an outpatient, and was delivered per primary 
caesarean in the 39th week due to cephalopelvic disproportion. The healthy 
male infant weighed 3690g and had APGAR 10/10.The double fist large 
cauliflower fibroid appeared partially necrotic and had a 3cm base and was 
intra-operatively removed because of risk of causing problems postpartum due 
to its necrosis. The fibroid was removed without entering the uterine cavity and 
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a future spontaneous delivery was not threatened. The postpartum time was 
uncomplicated. 
 
This same patient went on to become pregnant again within two years of her 
initial caesarean. In the 39th week the patient was delivered via repeat 
caesarean because of the fear of uterine dehiscence. Truly, the area of the 
prior uterine incision was paper thin, and a 6cm defect only covered via serosa 
could be seen at the prior fundal myomectomy site. This 6cm defect extended 
all the way up to the tubal origin and could not be re approximated and was 
left unchanged. The patient was instructed to not get pregnant before the 
fundal dehiscence area was operatively corrected.  
 
The patient neglected the warnings and became pregnant again 3 years later 
without prior operative repair of the dehiscence. In the 15th week of pregnancy 
an MRI showed the dehiscence in the fundus and it was decided that a 
continuance of the pregnancy without intervention was too risky. The patient 
underwent a laparotomy, and the dehiscence area was covered with an 
ethicon ultrapro monocryl prolene patch. The patient was admitted to the 
hospital after the operation due to premature contractions which were stopped 
with tocolytics. The fetus was monitored via ultrasound every two weeks and 
showed normal growth. The contractions returned in the 32nd week and could 
no longer be stopped with tocolysis.  
 
The patient was delivered via repeat caesarean, revealing an adherent 
Peritoneum to the patch. A hysterectomy was performed by completed family 
planning and the patient had an uneventful postpartum. 
 
 
Patient 19 
 
41 year old G2P1 was first seen in the 21st week of pregnancy with premature 
contractions, and lightly increased infection parameters. The patient received 
intravenous antibiotics and analgesics (ibuprofen, paracetamol) and via 
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ultrasound a placenta previa as well as a large uterine fibroid measuring 
8,2cm x 6,7cm were found. The fibroid was known before pregnancy to be 
3,5cm. Due to a new rise in the infection parameters (elevated CRP) an MRI 
was performed which showed a necrotic 8,5cm x 6,4cm fibroid between the 
rectum and the bladder, as well as a second 4,9cm x 4,2cm intramural fibroid. 
Renewed antibiotic therapy reduced the pain as well as the infection 
parameters. In addition the patient received ibuprofen, and paracetamol. The 
pregnancy continued uneventfully and the patient was delivered in the 37th 
week via longitudinal caesarean of a 2720g male newborn, with APGARS 
10/10. During the caesarean the large posterior fibroid near the rectum, 
showing degenerative changes was removed, leaving the other smaller fibroid 
behind. The histology showed no increased mitotic activity and no atypical 
cells, ruling out a sarcom. 
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4. Results 
 
4.1 Distribution of Patients 
 
We conducted a retrospective observational study of 19 pregnant patients, 
with a median age of 35 years, all with large uterine fibroids ranging from 8-25 
cm in size, referred to the university clinic of Großhadern in Munich, Germany, 
between 1996 and 2007 either due to symptoms or due to routine registration 
for delivery. 
 
As depicted in Table 2 - Study Design, 7 (37%) of these Patients were 
followed as asymptomatic ambulatory patients, 12(63%) patients were 
admitted to the hospital with complaints varying from vaginal bleeding, 
abdominal pain, increased infection parameter, and premature contractions. 
From the 12 admitted patients, 9(75%) received conservative medical therapy 
and 3(25%) underwent myomectomy between the 19th and 21st week of their 
pregnancy. The decision to treat surgically was based on the characteristics of 
the fibroids and their symptoms, and non-response to initial conservative 
therapy. 5(26%) Women delivered spontaneously. 14 (74%) patients were 
delivered via caesarean section following the threshold of viability: 11(79%) via 
primary caesarean and 3(21%) via secondary caesarean. 4(29%) of the 
patients undergoing caesarean required hysterectomy, and only 1(25%) of the 
hysterectomy patients had undergone myomectomy during the pregnancy.  
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19 patients with 
large fibroids 
63% increase 
in fibroid size 
12 patients 
symptomatic 
7 patients 
assymptomatic 
as outpatients 
21% no 
change in 
fibroid size 
16% decrease 
in fibroid size 
1 patient 
hysterectomy 
9 patients 
abdominal pain 
5 patients 
premature 
labor 
3 patients 
vaginal 
bleeding 
9 patients 
conservative 
therapy 
3 patients 
operated 
myomectomy 
1 patient 
delivered 
spontaneously 
8 patients 
delivered via 
Cesarean 
2 patients 
hysterectomy 
1 patient 
hysterectomy 
3 patients 
cesarean 
4 patients 
delivered 
spontaneous 
3 patients 
Cesarean 
Table 2:  The Study Design 
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4.2 Age at Presentation 
 
All patients presented at differing gestational ages ranging between the 7th and 
37th weeks of gestation. Patient ages ranged from 26-42 years of age, with the 
mean age being 35.  (Table 3) All pregnancies with the exception of one, via 
assisted reproductive therapy (ICSI-Pt. 6), were spontaneous and in three 
patients subsequent to prior first trimester spontaneous abortions (Patients 8, 
12, 19). 
 
 Patient initials Patient age Delivery date 
Patient 1) KE 39 5/2002 
Patient 2) SY 37 2/2002 
Patient 3) SK 33 4/2002 
Patient 4) HMD 29 5/2002 
Patient 5) RH 38 7/2002 
Patient 6) HGE 29 4/2002 
Patient 7) ZG 38 7/2002 
Patient 8) GS 33 12/1996 
Patient 9)    
Patient 10) SS 42 10/2007 
Patient 11) HS 33 1/2002 
Patient 12 RD 30 1/2004 
Patient 13) SA 26 1/2003 
Patient 14) RA 36 11/2002 
Patient 15) NG 42 10/2003 
Patient 16) DB 37 5/2001 
Patient 17) SMP 39 9/2003 
Patient 18) FS 33 12/2004 
Patient 19) SB 41 10/2006 
Table 3:  Study Patients 
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4.3 Symptoms at Presentation
 
With the exception of seven asymptomatic patients, all other patients 
presented with pain, contractions, or vaginal bleeding as their primary 
complaint and reason for hospital admission. Twelve patients were admitted to 
the hospital between 18 and 33 weeks of gestation for a length of one to 
thirteen weeks prior to delivery.  
 
Increased 
infection 
Parameters  
Premature 
Contractions 
 Abdominal pain 
(11-33w) 
Vaginal bleeding 
(13-17w) 
3, 6, 10,14, 19 
(42% of 
symptomatic 
patients) 
4, 6, 12, 19 (33% of 
symptomatic 
patients) 
2, 3, 4, 5,6, 8, 9, 10, 
12, 14 
(83% of 
symptomatic 
patients) 
1, 5,6 (25% of 
symptomatic 
patients) 
Asymptomatic 
Pts. 7, 11, 13, 15, 
16, 17, 18 (37% of 
all patients) 
   
Table 4:  Chief complaints leading to admission of pregnant patients with fibroids 
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4.4 Prior Myomectomy
 
Three patients (Patients 4, 5, 7) had a myomectomy prior to their current 
pregnancy (two via laparoscopy (Patients 5, 7), one via laparotomy (Patient 4).  
 
 
 
 Myomectomy 
during  
Pregnancy 
Cesarean 
Delivery 
Hysterectomy 
With  Delivery  
Spontaneous 
Delivery 
Prior 
myomectomy 
3 Patients 
(4,5,7 ) 
0 3 Patients 
(4, 5, 7) 
2 Patients 
(4, 7) 
0 
No prior 
myomectomy 
16 Patients 
3 Patients 
(8, 9, 10) 
11 Patients 
(1, 2, 3, 6, 8, 9, 
10, 14, 15, 18, 
19) 
2 Patients 
(3, 10) 
5 Patients 
(11, 12, 13, 16, 
17) 
Table 5:  Mode of Delivery with vs. without Prior Myomectomy 
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4.5 Diagnosis and Dynamic of the fibroids during Pregnancy 
 
Ultrasound confirmation of the fibroids was based on criteria described by 
[Muram et al. 1980 ]: 1) spherical mass greater than 3cm in diameter, 2) 
distortion of the myometrial contour by the mass, and 3) differentiation of the 
mass from the myometrium by different acoustic structure as seen on 
ultrasound. The myoma was characterized as retroplacental in location when 
an intramural or submucous mass was present deep to the placenta, as 
described by Lev-Toaff et al.1987 The location of the fibroids were classified 
as by Benson et al as submucosal if part of the fibroid bordered on or 
protruded into the endometrium, intramural if the fibroid was within the wall of 
the uterus surrounded by myometrium, and subserosal if the fibroid extended 
to the serosal surface of the uterus. 
 
In eight Patients (Patients 1, 3, 4, 5, 8, 10, 13, 19) an MRI was done in 
addition. (Table 7.) An MRI was usually done by patients with prior 
myomectomy or caesarean to assess the uterine wall thickness, and to decide 
delivery modus. According to Rozenberg [Rozenberg et al. 1996] a trial of 
labour could be proposed when the thickness of the lower uterine segment is 
>3,5mm. In patient 7 no MRI was performed because the patient had two 
spontaneous deliveries two and three years following her laparoscopic 
myomectomy and was also first seen as she came to register for her delivery 
in our clinic in the 37th gestational week. She had been asymptomatic 
throughout her whole pregnancy. 
 
The majority of patients, 79%, had multiple fibroids. Only 21% had a single 
large fibroid. The types of fibroids and structure of fibroids as well as their 
relationship to the placenta are listed in table 7. 
 
 
Interestingly enough as depicted in Table 6: 16 % of the fibroids decreased in 
size during gestation, 63% increased in size and 21% showed no change. 
From the fibroids which showed increase in size during the pregnancy four 
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(33%) showed signs of contact to the placental bed, and 7 (58%) showed 
signs of necrosis. From the fibroids which showed no change in size during the 
pregnancy 2 of the four (50%) interestingly enough showed signs of necrosis, 
as opposed to none in the group of fibroids which showed a decrease in size 
during pregnancy. 
 
 
 Patients % 
Single Fibroid 11, 12, 13, 17 21 
Multiple Fibroids 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 
14, 15, 16, 18, 19 
79 
No change in Fibroid size 15, 16, 17, 19 21 
Decrease in Fibroid size 2, 5, 11 16 
Increase in Fibroid size 1, 3, 4, 6, 7, 8, 9, 10, 12, 
13, 14, 18 
63 
Placenta adjacent to 
fibroid  
1, 3, 7, 8, 10, 18 32 
Table 6:  Change in size of Fibroid during pregnancy 
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Pt. 
# 
GW Fibroid 
Position 
Fibroid 
Type 
Fibroid
size 
in mm 
Fibroid structure Placenta MRI Symptoms 
1 7 Cervix intramural 17x18x12 inhomogen. with 
subacute bleed 
Fundal-
contact 
with 2 
fibroids 
yes vag. 
bleeding 
2 14 Posterior 
right 
transmural 120x120 
x120 
homogeneous 
structure 
Anterior no abd. pain, 
3 21 side wall 
right 
intramural 150x120 barely 
vascularised 
side wall 
right low 
lying 
yes pain,crp 
4 15 Cervix subserosal 150x130 inhomogen. posterior yes abd. pain,  
5 22 side wall 
left  
intramural 138x70 Myxoid-
degenerative 
changes 
side wall 
left 
yes abd. pain,  
vag. 
bleeding 
6 9 Fundal subserosal 90 inhomogen, 
central necrosis 
di di 
Gemini 
no vag. 
bleeding 
7 37 anterior  intra-
ligament 
120x100 homogeneous Anterior no none 
8 18 Fundal subserosal 145x145 
X130 
6cm growth within 
4 weeks myxoid 
deg. 
fundal-
contact 
with 
fibroid 
yes abd. pain,  
9 19   140    abd. pain,  
10 18 Cervix transmural 144x121 
x112 
central necrosis adj. to 
placenta, 
previa 
totalis 
yes abd. pain, 
Hydronephr
osis 
11 11 Anterior intramural 114x87 
x117 
homogeneous posterior no none 
12 33 Fundal intramural 80x80x80 homogeneous posterior no premat Cxs 
13 16 Anterior transmural 97x90x77 inhomogen, 
central necrosis 
posterior 
adjacent 
to fibroid 
yes none 
14 10 Side wall 
right 
transmural 118x82x8
2 
central necrosis anterior no abd. Pain, 
CRP 
15 8 Side wall 
right 
subserosal 86x65x50 homogeneous anterior no none 
16 28 Side wall 
right 
transmural 89x84x72 homogenous fundal no none 
17 12 Side wall 
right 
transmural 110x90 inhomogen, 
central necrosis 
side wall 
left-
contact w: 
fibroid 
no none 
18 10 Fundal intramural 140x80 
x80 
inhomogeneous 
central necrotising 
area 
posterior 
adjacent 
to fibroid 
no none 
19 21 between 
rektum/ 
bladder 
intramural 85x64 central necrosis previa 
totalis 
yes none 
Table 7:  Fibroid numbers, types and relation to Placenta 
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4.6 Mode of Delivery
 
Fourteen of the nineteen patients were delivered through caesarean between 
the 26th and 41st week. Eleven of these fourteen caesareans were primary 
(main reason being the existence of a large fibroid, one transverse fetal 
position, one due to desire to avoid vaginal birth, one presumed placenta 
previa and one due to premature rupture of membranes and amnion infection 
syndrome in the twin gestation with ICSI in the 26th week.) Three caesareans 
were secondary (one due to arrest of labour, one due to fetal distress signs on 
cardiotocograph and one due to vaginal bleeding and a feared  partial 
placental abruption).  
 
 Myomectomy 
during  
Pregnancy 
Cesarean 
Delivery 
Hysterectomy 
with  Delivery  
Spontaneous 
Delivery 
Prior 
myomectomy 
3 Patients 
(4,5,7 ) 
0 3 Patients 
(4, 5, 7) 
2 Patients 
(4, 7) 
0 
No prior 
myomectomy 
16 Patients 
3 Patients 
(8, 9, 10) 
11 Patients 
(1, 2, 3, 6, 8, 9, 
10, 14, 15, 18, 
19) 
2 Patients 
(3, 10) 
5 Patients 
(11, 12, 13, 16, 
17) 
Table 8:  Mode of Delivery with vs. without Prior Myomectomy 
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Pt. 
# 
GA 
Adm 
Dur.  
Adm 
Prior 
OP 
Therapy GA 
Deliv 
Mode 
Deliv. 
Fibr@ 
Deliv 
Fibr 
remov 
Compli- 
cations 
GP 
           
1 13 5 no conserv. 39+0 prim. Cesa 20cm no none G1P1 
2 12 2 no conserv. 40+2 sek. Cesa 8x8cm no none G1P1 
3 21 13 no conserv. 33+2 prim. Cesa 25cm yes 
HE 
reop/HE G1P1 
4 15 3 LapM conserv. 32+6 prim. Cesa 15,6x11 yes 
HE 
HE G1P1 
5   LSK M 
-Ut 
op/Ces
ar 
outpatient 39+0 prim. Cesa 12x6cm no postp 
fever 
G2P2 
6 9 2 LSK 
diagn. 
conserv. 25+4 prim. Cesa 
Di.Di.Twins 
4x9cm yes none G1p2 
7   LSKM. outpatient 38+1 prim. Cesa 12x12 
Zervix 
yes 
HE 
HE G3p3 
8 18 2 no op19w 35+4 prim. Cesa 1575g  
19w 
yes 
18w 
lack of 
right hand 
G2P1 
9 19   op 19w 37+0 prim. Cesa 14cm 
19w 
Yes 
19w 
none 
 
10 18 24 yes 
Cesar
ean 
op 21w 35+2 prim. Cesa HE Yes 
21w 
bleeding/
HE 
G2P2 
           
11   no outpatient 38+0 spont. 
Vacuum 
10x10 no none G4P1 
12 33 1 no conserv. 32+5 spont. 8x8cm no none G2P1 
13 0 0 no outpatient 41+5 spont. 10cm no none G1P1 
14 10 1 no conserv. 39+0 sek.Cesa 12x8cm no none G1P1 
15   no outpatient ET+4 sek.Cesa 8cm no Placental
Abruption 
G2P2 
16   no outpatient 37+0 spont. 8,9cm no none G3p3 
17   no outpatient 35+2 spont. 9cm no none G3p3 
18   LSK 
diagn. 
94 
outpatient 38+5 prim. Cesa 15cm yes  none G1P1 
19 21 17 no conserv. 37+0 prim. Cesa 85cm yes none G2P1 
 
Table 9:  Mode of Delivery 
 
 
4.7 Hysterectomy at time of Delivery 
 
Four patients according to Table 9 underwent caesarean deliveries with 
subsequent hysterectomies. The first of these patients was delivered in the 
34th week because of persistent contractions and an MRI showing a uterine 
wall thickness in an area of prior myomectomy of less than one centimeter, 
and the associated risk of uterine rupture. During the caesarean, a 
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hysterectomy needed to be performed due to uterine atony and uncontrollable 
bleeding from the uterine incision.   
 
The second patient underwent a hysterectomy five days following caesarean 
delivery, at which time a large 25cm anterior wall fibroid was left behind with 
the plan of future removal following postpartum involution. During the following 
four days the patient developed fever and complained of right sided abdominal 
pain. Due to an acute abdomen the patient underwent a second exploratory 
laparotomy at which time the 25cm fibroid was removed and an appendectomy 
for a chronically inflamed appearing appendix (most likely in association with 
the prior caesarean), was performed.  Due to uncontrollable vaginal bleeding 
following closure of the abdomen, the patient was operated within 12 hours of 
the second laparotomy again and received a hysterectomy as well as a blood 
transfusion. Mother and child were discharged 3 weeks later in good condition. 
 
The third of these patients, the patient with the fetus in transverse position and 
a 12cm cervical/intraligamentary fibroid following an uncomplicated caesarean 
underwent a hysterectomy due to completed childbearing and risk of 
worsening of the existing rotation of the uterus and risk of postpartum 
degeneration of the large fibroid.   
 
The last patient undergoing hysterectomy at the time of caesarean delivery 
underwent uterine removal due to uncontrollable lower uterine segment 
bleeding. She was the only one from all hysterectomy patients who had 
undergone a myomectomy during the pregnancy.  
 
4.8 Myomectomy during Pregnancy 
 
The three patients who underwent myomectomies during their pregnancies all 
presented with abdominal pain resistant to medical therapy.  
 
In one of the three patients the fibroid in addition to causing pain also showed 
a rapid growth of 6cm within a 4 week period. This was an additional factor for 
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surgical removal, due to the potential concern of malignancy and as the final 
pathology report showed, the fibroid had an increased mitotic activity and was 
classified as a leiomyoma neoplasia of uncertain malignancy. This patients 
remaining fibroids were subsequently followed with monthly ultrasound and 
MRI and remained quiescent during the pregnancy. The second patient had a 
right hydronephrosis which was being caused from her 14cm right sided 
fibroid. Due to worsening hydronephrosis und due to persistent signs of 
necrosis which was feared to cause further problems during the remaining 20 
weeks of pregnancy, the decision was made to remove the necrotic fibroid in 
the 21st week.  
 
4.9 Infant Outcome
 
All 20 infants were live born without malformations, with the exception of one 
infant born with a limb defect, to a mother who had undergone myomectomy 
during her pregnancy (Patient 8). 
 
All infants as depicted in Table 10, with the exception of one (1890g. in the 
34th week) were born with a weight appropriate for their gestational age. This 
SGA newborn (10% in the 34th week-1973g) , born to the mother with the 
25cm fibroid, requiring two laparotomies and a hysterectomy postpartum, had 
APGARS of 5/7/8/9,  was stable on room air, and was discharged four weeks 
later without complications with his mother. Three other newborns had initial 
low APGARS, among them the premature dichorionic-diamniotic twins both 
born with APGARS of 4/5/8/8, requiring immediate intubation, and the infant 
born in the 33rd week with 7/8/8/8 initially requiring CPAP.  The remaining 4 
infants all had initial APGARS over 9. 
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Pt.# GA 
Deliv 
Delivery 
Mode 
Birth 
weight 
in g 
Apgars 
5 and 
10min 
Size 
Fibr@Deliv 
Fibr 
remov 
Complication 
1 39+0 prim. Cesa 2820 9,10 20cm no none 
2 40+2 sek. Cesa 3100 9,10 8x8cm no none 
3 33+2 prim. Cesa 1890 8,9 25cm yes/HE reop/HE 
4 32+6 prim. Cesa 2120 8,8 15,6x11cm yes HE HE 
5 38+4 prim. Cesa 3580 10,10 12x6cm no postp fever 
6 25+4 prim. Cesa 
Di.Di Twins 
770,750 8,8 4x9cm yes none 
7 38+1 prim. Cesa 2730 9,10 12x12cm cervix yes HE HE 
8 35+4 prim. Cesa 2495 8,9 1575g 19w yes 18w lack of right hand 
9 37+0 prim. Cesa   14cm 19w Yes 19w none 
10 35+2 prim. Cesa 2570 9,10 HE Yes 21w bleeding/HE 
11 37+5 spontVacuum 2610 10,10 10x10cm no none 
12 32+6 spontaneous 2110 9,9 8x8cm no none 
13 41+5 spontaneous 3820 10,10 10cm no none 
14 39+0 sek.Cesa 3330 10,10 12x8cm no none 
15 40+4 sek.Cesa 3260 10,10 8cm no Placental 
Abruption 
16 37+0 spontaneous 3420 9,9 8,9cm no none 
17 35+2 spontaneous 2530 9,10 9cm no none 
18 38+5 prim. Cesa 3690 10,10 15cm yes  none 
19 37+0 prim. Cesa 2720 10,10 85cm yes none 
        
 
Table 10:  Neonatal Outcome 
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5.  Discussion 
 
Fibroids are the most common solid pelvic tumours in women, occurring in 20-
25% of women in their reproductive years and with an incidence between 
0,3% and 2,6%  in pregnant women [Zaloudek et al. 1987, Muram et al. 1980]. 
Uterine fibroids are observed more frequently in pregnancy nowadays, due to 
woman’s delayed childbearing into their thirties, the age where fibroids are 
most likely to grow. Women with leiomyomas were more likely to be over the 
age of 35 at delivery, nulliparous or black [Coronado et al. 2000].  
Although most fibroids remain asymptomatic, they may complicate the course 
of pregnancy, labor and delivery.  Complications that may arise in 10-40% of 
pregnant women with uterine fibroids [Exacoustos et al. 1993, Mollica et al. 
1996], include increased frequency of spontaneous abortion, placental 
abruption, premature rupture of membranes, premature labor, fetal 
malpresentation, postpartum hemorrhage  postpartum sepsis and postpartum 
hysterectomy [Mollica et al. 1996]. According to Coronado et al., complications 
in pregnancy, labour and delivery were nearly twice as frequent among 
women with diagnosed uterine fibroids than among those without them. Such 
complications are dependent on the size, location and relation of the fibroid to 
the placenta, and they may arise during pregnancy, at delivery or postnatally 
[Coronado et al. 2000]. 
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Spontaneous abortion 
Preterm labor 
Premature rupture of membranes 
IUGR-Intrauterine Growth Retardation 
Malpresentation 
Caesarean birth 
First trimester bleeding 
Placental abruption 
Oligohydramnion 
Placenta previa 
Fetal malformations 
Pain (compression or fibroid degeneration) 
Fever 
Uterine compression (Hydronephrosis) 
Birth obstruction 
Postpartum involution disorder and atonic bleeding 
 Table 11: Possible Complications of Fibroids in Pregnancy 
 
 
The actual mechanism through which the uterine fibroids cause the above 
pregnancy, and labour complications is unclear. Whether the restriction in 
space, fetal growth and movement or interference with the effectiveness of 
labour contractions or obstruction of labour through lower uterine segment 
fibroids, the exact mechanism behind the complications arising from large 
fibroids is unclear [Coronado et al. 2000]. Interestingly enough, the Coronado 
study showed that women with uterine fibroids  were at a higher risk for poor 
birth outcomes, defined as newborns with APGAR scores less than 7, with 
low-birth weight <2500g or with malformations. Whereas Coronado in her 
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large population-based study observed that uterine fibroids were strongly 
related to caesarean delivery and low birth weight, Exacoustos [Exacoustos et 
al. 1993] as well as Muram [Muram et al. 1980] found that mode of delivery 
and fetal growth were not affected by the presence of fibroids. Rice [Rice et al. 
1988] found no significant incidence of intrauterine growth retardation (IUGR) 
or low APGAR scores in his population of pregnant women with uterine 
fibroids. In our small collective there was one small for gestational age infant 
born in the 34th week of gestation to a mother with a large 25cm fibroid, which 
most likely caused a structural restriction of intrauterine fetal growth. In our 
study this newborn as well as the two premature 27th week twins had APGAR 
scores less than 7. Otherwise all other infants, including both infants born to 
the two patients that underwent myomectomy during pregnancy had APGAR 
scores of 9 or better, and weights appropriate for their gestational age. In our 
study there was no miscarriage and no perinatal death. One of our newborns 
in the study however did have a malformation in the form of a missing right 
hand. 
 
In a study by Exacoustos [Exacoustos et al. 1993], an increased risk of 
abruption was associated with submucosal, retroplacental fibroids, with 
volume greater than 200 cm. This association between fibroids and placental 
abruption is shown in Coronado’s study [Coronado et al. 2000] to be even 
stronger as previously reported, with a nearly fourfold increase of placental 
abruption among women with uterine fibroids. Muram [Muram et al. 1980] in 
his study concluded that the relationship between the location of the fibroids 
and the placental site emerged as a significant prognostic clue to the outcome 
of the pregnancy. In our patient group although three patients had 
retroplacental fibroids, one of which underwent myomectomy, there was no 
occurrence of placental abruption.  
 
The standard rule for fibroids in pregnancy is conservative management. In a 
study of 64 pregnant patients with uterine fibroids Döring [Döring et al. 1987], 
confirmed that under conservative management 2/3 of the pregnancies 
remained uncomplicated, 9/10  reached the 38th week and that spontaneous 
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births were two times higher than caesarean. We suggest that medical therapy 
including analgesics, fluids, antibiotics and prostaglandin inhibitors may be of 
use in patients who do not fit the high risk group.  High risk groups are those 
with symptoms resistant to medical therapy, with complaints since the early 
pregnancy, patients with an increased rate of fibroid growth and fibroid 
degeneration, patients with retroplacental fibroids and patients who have 
undergone prior myomectomies. According to Dubuison [Dubuisson et al. 
2000] patients having undergone a laparoscopic myomectomy have a 1% 
uterine rupture risk.  This risk can be associated with the use of unipolar 
electrocautery during the laparoscopic myomectomy, as shown in the case 
report by Hasbargen et al. 2002, stemming from the same institution as our 
study. Patients in whom there is a close proximity between fibroid and 
placental site seem to be at greater risk and should be followed more carefully. 
Muram and Rice [Muram et al. 1980, Rice et al. 1988] found that leiomyomas 
that were located retroplacental were associated with a higher incidence of 
adverse outcome such as premature rupture of membranes, antepartum 
bleeding and postpartum hemorrhage. Conversely, Lev-Toaff [Lev-Toaff et al. 
1987] believed that leiomyoma location with respect to the placenta did not 
increase these complication rates. In such patients an MRI can reveal the 
relationship of placenta to fibroid as well as assess the thickness of 
myometrium at prior myomectomy sites. Interestingly enough, the one patient 
with a thin uterine wall at the fundus area was patient 4 who had undergone a 
myomectomy via laparotomy, whereas the two patients with prior laparoscopic 
myomectomies (Patient 5 and Patient 7) had no signs of increased risk for 
uterine dehiscence. According to Muram [Muram et al. 1980] in this high risk 
subgroup of patients a timely, well planned myomectomy should be an option 
offered to the patient, avoiding the morbidity and mortality associated with 
emergency procedures. According to Burton [Burton et al. 1989] if symptoms 
persist following 72 hours of medical therapy, surgical intervention must be 
considered. 
 
In regards to the three patients that were operated, when one looks at the 
literature with regard to myomectomy during pregnancy, there is much 
  
46 
controversy.  Although Phelan [Phelan 1995] believes that myomatous 
degeneration resistant to medical therapy is an indication for surgical 
intervention, he limits myomectomy to pedunculated fibroids with stalks no 
larger than 5 cm, and avoids dissection of fibroids from the uterine wall due to 
risk of bleeding and resulting hysterectomy. Phelan also recommends 
postpartum removal of fibroids having caused pregnancy complications prior 
to the next pregnancy allowing first a potential decrease in size through 
postpartum uterine involution. Most authors caution against elective 
myomectomy at time of caesarean because of increased morbidity especially 
haemorrhage. Burton [Burton et al. 1989] showed that elective myomectomy 
at caesarean may be safe in carefully selected patients. From a series of 13 
patients with incidental myomectomy during caesarean only one was 
complicated by intraoperative haemorrhage. In our study, 3 patients 
underwent a myomectomy during caesarean. The main reasons for the 
myomectomies were the interference of the fibroids with uterine closure or due 
to existing signs of degeneration/necrosis which would increase the risk of 
postpartum symptoms-possibly requiring additional medical or surgical 
therapy.  
 
The risk of surgery associated spontaneous abortion has also been raised, but 
refuted by Mollica [Mollica et al. 1996] who found a 13.6% spontaneous 
abortion rate in conservatively treated pregnant patients with fibroids, and a 
rate of zero in the surgically treated group. The conservatively treated group 
also had higher premature membrane rupture and preterm labour rates, and 
4.5% of them required post-caesarean hysterectomies. In our study there was 
no spontaneous abortion in the myomectomy during pregnancy group and no 
fetal loss in both operated and conservatively managed groups. According to 
Mollica [Mollica at al. 1996] the lowest incidence of abortion is reported after 
myomectomies performed electively, while the highest incidence occurs after 
emergency operations for acute complications. His study showed that elective 
surgery does not increase the incidence of spontaneous abortion in pregnancy 
with fibroids, and it moreover improves fetal and neonatal outcome [Mollica et 
al. 1996]. The only neonatal death occurred in Mollicas study, in the patient 
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who refused surgery. Mollicas data regarding elective conservative 
management of fibroids in pregnancy have shown better results compared 
with those regarding untreated patients. However conservatively treated 
patients had a higher incidence of premature labor, premature rupture of 
membranes and preterm labor compared to the nontreated or to the surgically 
treated group. Mollica concludes patients with a myoma that may compromise 
the outcome of pregnancy should be operated on, whereas all the others 
should be treated conservatively [Mollica et al. 1996]. Our three patients were 
electively operated under controlled circumstances, and their fetal outcome 
was good. Another study from Lolis [Lolis et al. 2003] confirms this view by 
stating that there are two basic complications of myomectomy during 
pregnancy: abortion and haemorrhage. 
 
Exacoustos [Exacoustos et al. 1993] study data suggest that myomectomy 
during pregnancy has a high preterm delivery rate with a good perinatal 
outcome when performed in patients selected on the basis of clinical and 
ultrasound criteria, and that the decision to perform myomectomy during 
caesarean delivery must be made with caution because of the risk of 
haemorrhage.  According to Exacoustos [Exacoustos et al. 1993] the use of 
ultrasound in detecting myoma position, size, location, relation to placenta and 
echogenic structure can aid in identifying women at risk for fibroid-related 
complications in pregnancy.  According to Muram [Muram et al. 1980], clinical 
detection of the fibroids depended on their size and location. Only two of 16 
fibroids between 3 and 5 cm. were found by physical examination, whereas 
there was a pickup rate of 80% when the fibroid was larger than 10cm. All the 
fundal, corneal, and isthmic fibroids were detected clinically. Fibroids that were 
situated on the corpus uteri often escaped detection. The overall rate of 
clinical diagnosis was 42%. The location of the fibroid especially its 
relationship to the placental site is more significant than its actual size in 
predicting pregnancy outcome. According to Rice [Rice et al. 1988], patients 
with fibroids >3cm had a significant increased rate of premature labour, 
placental abruption, pelvic pain and caesarean section, whereas fibroids <3cm 
were not clinically significant. The rate of placental abruption in patients with 
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submucosal location of the myoma was 31% according to Exacoustos 
[Exacoustos et al. 1993]. 
 
Fibroids increase in size during pregnancy under the influence of estrogen and 
a better blood supply. According to Rosati [Rosati et al. 1992] myoma growth 
occurs in the first trimester, particularly prior to 10 weeks of gestation and he 
advises sonographic monitoring in pregnancy, particularly during the first 
weeks of gestation. In our study however, the 63% of fibroids that increased 
during gestation all showed growth after the 10th week of gestation. These 
results differ with those of Phelan [Phelan 1995] showing that 80% of uterine 
fibroids during pregnancy remained the same or decreased in size. In our one 
patient (Patient 8) the concern for a possible malignancy had been considered 
with regards to the rapidity with which the patients fibroid had grown over the 4 
weeks prior to surgery, even though according to Parker [Parker et al. 1994], 
the association between rapid growth of leiomyoma and sarcoma is not 
substantiated. In Muram’s [Muram et al. 1980] study in 38 out of 41 patients 
there was no demonstrable change in fibroid size, whereas in two patients an 
increase of up to 25% was noted and one patient’s fibroid diminished in size 
by 20%. This is in agreement with Phelan’s [Phelan 1995] thumb rule of 20% 
of fibroids increase during the course of pregnancy and 80% remained the 
same or decreased in size. In our study, aside from the one patient with rapid 
myomal growth and histologic borderline lesion, in the majority of patients 
(63%) the fibroids increased in size. In 21% the fibroids did not change in size 
and in 16% even grew smaller. The risk of acute red degeneration of a myoma 
is a problem which occurs between the 14th and 20th weeks when the growth 
of the uterus is most active. In Hasan’s study it occurred in 10% of pregnant 
patients and they were all treated conservatively with bed rest and analgesics 
and the symptoms usually subside within 10 days [Hasan et al. 1990]. 
According to Exacoustos, the necrotic areas are a perfect medium for 
anaerobic infection, which may be resistant to therapy. Myoma degeneration 
with pelvic pain resistant to medical therapy should be an indication for 
myomectomy during pregnancy. However in Exacoustos’s study, only myomas 
that were subserous or pedunculated and caused severe pain resistant to 
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therapy were considered for removal before 26 weeks of gestation 
[Exacoustos et al. 1993]. 
 
A final point of interest meriting discussion is the unexpected limb defect found 
at birth in one of our patients having undergone a myomectomy during 
pregnancy. There have been a few cases in the literature, of fibroid associated 
fetal limb defects, thought to stem from the spatial restriction caused by large 
fibroids [Danzer et al. 2001, Graham et al. 1980, Romero et al. 1981]. Danzer 
et al. report the only case associating a fetal limb defect and hydrocephalus in 
one twin, in a dichorionic diamniotic twin pregnancy, with a perioperative 
retroplacental haemorrhage possibly resulting from a myomectomy performed 
at 10 weeks of gestation [Danzer et al. 2001]. In Grahams case, a 10cm 
cervical fibroid was found in conjunction with a hypoplastic right lower leg and 
foot in a femaIe infant [Graham et al 1980], and in Romeros case an infant 
with a head deformation and congenital torticolis [Romero et al. 1981], both of 
which did not undergo a myomectomy during pregnancy.  
 
In our patient, the surgery itself is unlikely to have caused the limb defect, 
since it was performed at 19 weeks gestation and the fetal membranes were 
never violated.  In addition, during retrospective review of the imaging studies 
prior to the patient’s myomectomy, the fetal limb defect could be visualised, 
and it was most likely no diagnosed prenatally due to human error. Thus, 
pregnant patients with large myomas, should have thorough fetal anatomical 
scans due to the possible restrictive effect of the fibroids, which may lead to a 
higher risk for fetal limb abnormalities.  
 
A multitude of factors must be considered before arriving at the best course of 
management in any given pregnant woman with fibroids.  A thorough 
understanding of the pathogenesis of uterine myomas, clinical presentation, 
and the available diagnostic tools are the keys to selecting which course to 
follow in treating any given patient with fibroids.  Our data show that patients 
with large, retroplacental, rapid growing fibroids in pregnancy, whose 
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symptoms are resistant to medical therapy are candidates for myomectomy 
during pregnancy, for the purpose of improving pregnancy outcome.  
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6.  Summary 
Objectives: To present the indications for conservative medical therapy vs. 
myomectomy during pregnancy, as treatment of symptomatic large uterine 
fibroids and to discuss possible complications arising with either mode of 
therapy. 
Methods: A retrospective observational study of 19 pregnant patients, with a 
median age of 35 years, all with large uterine fibroids ranging from 8-25 cm in 
size, referred to the university clinic of Grosshadern in Munich, Germany, 
between 1996 and 2007 either due to symptoms or due to routine registration 
for delivery was conducted. 
Results: 7 (37%) patients were followed as asymptomatic ambulatory 
patients, and 12 (63%) patients were admitted to the hospital with complaints 
varying from vaginal bleeding, abdominal pain, increased infection 
parameters, and premature contractions. From the 12 admitted patients, 9 
(75%) received conservative medical therapy and 3 (25%) underwent 
myomectomy between the 19th and 21st week of their pregnancy. The decision 
to treat surgically was based on the characteristics of the fibroids and their 
symptoms, and non-response to initial conservative therapy. 5 (26%) Women 
delivered spontaneously. 14 (74%) patients were delivered via caesarean 
section following the threshold of viability: 11 (79%) via primary caesarean and 
3 (21%) via secondary caesarean. 4 (29%) of the patients undergoing 
caesarean required hysterectomy, and only 1 (25%) of the hysterectomy 
patients had undergone myomectomy during the pregnancy.  
All infants were live born without malformations, with the exception of one 
infant born with a missing limb, to a mother who had undergone myomectomy 
during her pregnancy.  
Conclusions: Certain known risk factors in pregnant women with fibroids such 
as size, continuous growth, texture and position of the fibroid in relation to the 
placenta, leading to symptoms not treatable via conservative methods, can 
predispose to complications during pregnancy. Women with such risk factors 
or women who have failed medical therapy, should be offered the option of 
undergoing myomectomy during pregnancy, in the hope of improving 
pregnancy outcome. 
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7.  Zusammenfassung 
 
Zielsetzung: Es sollen die Indikationen für konservative medizinischen 
Therapie vs. Myomektomie während der Schwangerschaft als Therapie 
symptomatischer großer Myome gezeigt werden und eine Diskussion über die 
bei der jeweiligen Therapieart auftretenden Komplikationen erfolgen. 
Methoden: Es wurde eine retrospektive Beobachtungsstudie von 19 
schwangeren Patientinnen mit einem mittleren Alter von 35 Jahren durchge-
führt, wobei alle Patientinnen große uterine Myome im Größenbereich von 8 
bis 25 cm aufwiesen und zwischen 1996 und 2007 entweder wegen Be-
schwerden oder aufgrund einer routinemäßigen Geburtsanmeldung an die 
Universitätsklinik Großhadern in München, Deutschland, überwiesen wurden. 
Ergebnisse: 7 (37%) Patientinnen wurden als asymptomatische  Patientinnen 
ambulant überwacht und 12 (63%) Patientinnen wurden aufgrund von Be-
schwerden, welche von vaginaler Blutung, abdominalem Schmerz, erhöhten 
Infektionsparametern bis zur vorzeitigen Wehen reichten, stationär aufge-
nommen. Von den 12 aufgenommenen Patientinnen erhielten 9 (75%) kon-
servative medizinische Therapie und 3 (25%) erhielten eine Myomentfernung 
zwischen der 19ten und 21ten Woche ihrer Schwangerschaft. Die Entschei-
dung einer chirurgischen Behandlung erfolgte auf Grundlage der Myomeigen-
schaften und deren Symptome sowie das Nichtansprechen auf anfängliche 
konservative Therapie. 5 (26%) Frauen entbanden spontan. 14 (74%) 
Patientinnen wurden mittels Kaiserschnitts nach Erreichen der Lebensfähig-
keitsgrenze entbunden: 11 (79%) mittels Primärsectio und 3 (21%) mittels 
Sekundärsektio. 4 (29%)  der durch Kaiserschnitt entbundenen Patientinnen 
benötigten eine Hysterektomie und nur bei 1 (25%) der Hysterektomie-
Patientinnen  war eine Myomentfernung während der Schwangerschaft durch-
geführt worden. 
Alle Neugeborenen waren Lebendgeburten ohne Missbildungen mit Aus-
nahme eines Neugeborenen mit einer fehlenden Extremität einer Mutter, bei 
der eine Myomektomie während ihrer Schwangerschaft durchgeführt worden 
war. 
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Schlussfolgerungen: Gewisse bekannte Risikofaktoren bei schwangeren 
Frauen mit Myomen, wie etwa Größe, fortgesetztes Wachstum, Oberflächen-
struktur und Position des Myoms in Bezug auf die Plazenta, welche zu nicht 
mittels konservativen Verfahren behandelbaren Symptomen führen, können zu 
einer Prädisposition bezüglich Komplikationen während der Schwangerschaft 
führen. Frauen mit derartigen Risikofaktoren oder Frauen, bei denen medi-
zinische Therapie nicht erfolgreich war, sollte die Option einer Myomektomie 
während der Schwangerschaft in der Hoffnung der Verbesserung des 
Schwangerschaftsergebnisses angeboten werden. 
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8.  Annex 
  
Pt.# GP GW Position of 
Fibroid 
Type of  
Fibroid 
Symptoms 
On 
Admission 
GA 
Adm 
Len 
Adm  
 
Prior OP Therapy 
          
1 G1P1 7 Cervix intramural vag. 
Bleeding 
13 5w no conserv. 
2 G1P1 14 Posterior right transmural abd. Pain, 12 2w no conserv. 
3 G1P1 21 side wall right intramural pain,crp, 21 13w no conserv. 
4 G1P1 15 Cervix subserosal abd. Pain, 
prem Ctxs 
15 3w LapM conserv. 
5 G2P2 22 side wall left  intramural abd. Pain,  
vag. 
Bleeding 
  LSK M  
prim.Cesa. 
outpatient 
6 G1p2 9 Fundal subserosal vag. 
Bleeding, 
abd. 
Pain,CRP 
9 2w LSK 
diagn. 
conserv. 
7 G3p3 37 anterior  intraligamen none   LSKM. outpatient 
8 G2P1 18 fundal subserosal abd. Pain,  18+0 2w no op19w 
9  19   abd. Pain,  19   op 19w 
10 G2P2 18 Cervix transmural abd. 
Pain,hydron 
CRP 
17+4 24w yes 
Cesarean 
op 21w 
11 G4P1 11 Anterior intramural none   no outpatient 
12 G2P1 33 fundal intramural prem Cxs 
abd. Pain 
32+5 1w no conserv. 
13 G1P1 16 Anterior transmural none 0 0 no outpatient 
14 G1P1 10 Side wall right transmural abd. Pain, 
CRP 
10 1w no conserv. 
15 G2P2 8 Side wall right subserosal none   no outpatient 
16 G3p3 28 Side wall right transmural none   no outpatient 
17 G3p3 12 Side wall right transmural none   no outpatient 
18 G1P1 10 fundal intramural none   LSK 
diagn. 
 94 
outpatient 
19 G2P1 21 Posterior 
between 
Rektum/Blader 
intramural fever, Pain 
CRP 
20+4 17w no Conserv. 
Table 12:  Additional Information on Study Patients  
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